Search research articles
Contact Us
Filters
Showing results (41-50 of 154) with videos related to
Page
of 16
Sort By:
Therapeutic Advances in Gastroenterology
|
October 21, 2021
Treatment in locally advanced rectal cancer: a machine learning bibliometric analysis
Francesca De Felice, Daniele Crocetti, Niccolò Petrucciani, et al.
Diagnostics (Basel, Switzerland)
|
August 26, 2023
Radio-Guided Lung Surgery: A Feasible Approach for a Cancer Precision Medicine
Miriam Conte, Maria Silvia De Feo, Viviana Frantellizzi, et al.
Clinical Neurology and Neurosurgery
|
July 21, 2019
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?
Paolo Tini, Valerio Nardone, Pierpaolo Pastina, et al.
World Neurosurgery
|
April 23, 2023
Clinical Efficacy of Adjuvant Radiotherapy for World Health Organization Grade II Intracranial Meningioma
Mauro Palmieri, Daniele Armocida, Raffaella De Pietro, et al.
Current Treatment Options in Oncology
|
January 14, 2020
Locally Advanced Rectal Cancer: Treatment Approach in Elderly Patients
Francesca De Felice, Daniele Crocetti, Veronica Maiuri, et al.
Anticancer Research
|
September 29, 2020
Toll-Iike Receptor-3 Activation Enhances Malignant Traits in Human Breast Cancer Cells Through Hypoxia-inducible Factor-1α
Francesca Scatozza, Antonella D'Amore, Rosaria Anna Fontanella, et al.
Brain Research Bulletin
|
June 22, 2019
Parkinson's disease and light: The bright and the Dark sides
Roberto Maggio, Francesca Vaglini, Mario Rossi, et al.
The Prostate
|
March 30, 2011
Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib
Giovanni Luca Gravina, Francesco Marampon, Margherita Piccolella, et al.
Biomedicines
|
February 26, 2025
The Tight Relationship Between the Tumoral Microenvironment and Radium-223
Miriam Conte, Miriam Tomaciello, Maria Silvia De Feo, et al.
The Prostate
|
April 10, 2014
Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models
Giovanni Luca Gravina, Francesco Marampon, David Sherris, et al.
Page
of 16
Search research articles
Search
Showing results (41-50 of 154) with videos related to
Sort By:
Page
of 16
Therapeutic Advances in Gastroenterology
|
October 21, 2021
Treatment in locally advanced rectal cancer: a machine learning bibliometric analysis
Francesca De Felice, Daniele Crocetti, Niccolò Petrucciani, et al.
Diagnostics (Basel, Switzerland)
|
August 26, 2023
Radio-Guided Lung Surgery: A Feasible Approach for a Cancer Precision Medicine
Miriam Conte, Maria Silvia De Feo, Viviana Frantellizzi, et al.
Clinical Neurology and Neurosurgery
|
July 21, 2019
Is a reduction of radiation dose feasible in patients affected by glioblastoma undergoing radio-chemotherapy according to MGMT promoter methylation status without jeopardizing survival?
Paolo Tini, Valerio Nardone, Pierpaolo Pastina, et al.
World Neurosurgery
|
April 23, 2023
Clinical Efficacy of Adjuvant Radiotherapy for World Health Organization Grade II Intracranial Meningioma
Mauro Palmieri, Daniele Armocida, Raffaella De Pietro, et al.
Current Treatment Options in Oncology
|
January 14, 2020
Locally Advanced Rectal Cancer: Treatment Approach in Elderly Patients
Francesca De Felice, Daniele Crocetti, Veronica Maiuri, et al.
Anticancer Research
|
September 29, 2020
Toll-Iike Receptor-3 Activation Enhances Malignant Traits in Human Breast Cancer Cells Through Hypoxia-inducible Factor-1α
Francesca Scatozza, Antonella D'Amore, Rosaria Anna Fontanella, et al.
Brain Research Bulletin
|
June 22, 2019
Parkinson's disease and light: The bright and the Dark sides
Roberto Maggio, Francesca Vaglini, Mario Rossi, et al.
The Prostate
|
March 30, 2011
Antitumor effects of carnertinib in castration resistant prostate cancer models: a comparative study with erlotinib
Giovanni Luca Gravina, Francesco Marampon, Margherita Piccolella, et al.
Biomedicines
|
February 26, 2025
The Tight Relationship Between the Tumoral Microenvironment and Radium-223
Miriam Conte, Miriam Tomaciello, Maria Silvia De Feo, et al.
The Prostate
|
April 10, 2014
Torc1/Torc2 inhibitor, Palomid 529, enhances radiation response modulating CRM1-mediated survivin function and delaying DNA repair in prostate cancer models
Giovanni Luca Gravina, Francesco Marampon, David Sherris, et al.
Page
of 16